H
Haleon
Haleon settled a $4.5 million lawsuit over false advertising of Robitussin products as non-drowsy despite containing an ingredient that can cause drowsiness.
ClosedUnited States-wideClaim status: Closed on May 12, 2025Payout: $1.50-$4.75 per claimNo longer claimable
About this settlement
The case addresses false advertising of Robitussin products marketed as non-drowsy but containing an ingredient that may cause drowsiness.
This settlement resolves claims that Haleon falsely advertised certain Robitussin products as non-drowsy despite containing dextromethorphan, an ingredient that can cause drowsiness. Eligible consumers who purchased these products during the specified period may receive compensation.
Who qualifies
- Consumers who purchased specified Robitussin products containing dextromethorphan.
- Purchases made between February 16, 2016 and January 21, 2025.
$1.50-$4.75 per claim
Claim status: Closed on May 12, 2025